Bariatric Surgery Remains Key Despite GLP-1 Drug Boom

As the use of GLP-1 weight-loss drugs skyrockets, the number of bariatric surgeries has dipped sharply, but experts emphasize that the procedure remains a vital, durable option for obesity treatment. Além disso, National insurance data from 2022 to 2024 shows a 140.4% surge in GLP-1 prescriptions, while metabolic bariatric surgery utilization fell by 34.1%. Yet leading surgeons say the operation is still the gold standard for many patients seeking significant, lasting weight loss. Contudo, The debate over which approach is better misses the point, they argue, as both medication and surgery have important roles in a comprehensive obesity management plan.

The Shifting Obesity Treatment Landscape

Ademais, Noel Williams, MD, of Penn Medicine in Philadelphia, acknowledged that weight-loss medications have decreased the number of surgeries performed. However, he and other experts insist that the procedure remains indispensable for many patients. The decline in surgery does not mean it has become obsolete; rather, it signals a changing treatment ecosystem where more options are available. Despite the statistical shift, the conversation is not about replacing surgery but about discerning when it is the most appropriate intervention.

When Is Surgery the Right Choice?

Além disso, Williams stated that patients with a significantly high BMI, those who have tried medications without losing enough weight, or those who cannot tolerate medications should still be surgical candidates. He underscored that surgery is still the gold standard in terms of weight loss.

Além disso, Christine Ren-Fielding, MD, of NYU Langone Health, noted that she still recommends surgery for many patients, but it depends on the individual case. Guidelines further specify that even without metabolic disease, surgery should be considered starting at a BMI of 30 for patients who fail to achieve substantial or durable weight loss through non-surgical methods. These recommendations are grounded in decades of clinical experience and reflect surgery’s proven track record.

Surgery Delivers Greater, More Lasting Results

Dessa forma, Bariatric surgery remains widely recommended because it generally results in greater, more durable weight loss. Por exemplo, A study showed covariate-adjusted mean fat-mass reductions of 49.7% with bariatric surgery and 18% with GLP-1 drug use at 24 months. Ren-Fielding pointed out that the benefit of surgery is more durable and requires less ongoing maintenance. This stark difference in long-term efficacy keeps surgery at the forefront of obesity treatment, especially for those who have struggled to maintain results with medication alone.

A New Era of Combination Therapy

Além disso, Clinicians are increasingly blending modalities in obesity management. Ademais, Ren-Fielding emphasized that medications and surgery should not be used in sequence but can be used in parallel to enhance each other’s efficacy. She has moved away from a sequential “first-line, second-line” approach to combination therapy. This shift represents a more nuanced understanding of obesity as a chronic disease requiring multifaceted approaches.

In fact, initiating a GLP-1 drug prior to surgery may carry distinct clinical benefits. Além disso, Preoperative weight loss can shrink liver volume and may reduce complication rates. In a prospective study of high-risk patients (BMI over 40) undergoing gastric bypass, achieving 5% to 10% preoperative weight loss was associated with significantly shorter hospital stay and faster postoperative weight loss. Such findings support the idea that the sum of these treatments can be greater than their individual parts.

Navigating Access and Side Effects

Despite the promise of medications, real-world obstacles often steer patients back to surgery. Além disso, Ren-Fielding noted that if patients don’t lose enough weight, they often return for surgery. Patients may pivot after encountering medication shortages, coverage denials, or side effects.

She also pointed out that access to medication can be interrupted, disrupting treatment, and that surgery offers more durable weight loss with less maintenance. Além disso, Williams added that lifetime changes are required for both surgery and weight-loss medications, and that side effects from medications persist as long as they are taken. These challenges highlight the need for a reliable treatment strategy that withstands the test of time and policy.

Weighing the Risks and Lifestyle Demands

Contudo, Surgery carries its own risks and dietary demands; patients should avoid overeating and certain foods to prevent complications. Por outro lado, Ren-Fielding highlighted that post-surgical side effects like dumping syndrome or post-bypass hypoglycemia don’t occur with GLP-1s.

Surgery also requires greater vigilance toward behavioral, lifestyle, and dietary changes. Both paths demand commitment, but the choice between them should be made in close consultation with a healthcare professional. As the landscape evolves, surgery remains a critical tool, offering hope to those who need it most. Ultimately, patients are urged to discuss all options thoroughly with their medical team.

Source

• www.medpagetoday.com
• national insurance data (jamanetwork.com)
• clinical practice guidelines (link.springer.com)
• cohort study (jamanetwork.com)
• shrink liver volume (link.springer.com)
• reduce complication rates (jamanetwork.com)